Skip to main content
Premium Trial:

Request an Annual Quote

Organon Taps Newhouse As Major Research Site

Premium

NEWHOUSE, Lanarkshire--Organon, the pharmaceutical business unit of Akzo Nobel has announced that it will invest £16 million to turn its research site here into the new center of the company's worldwide research into drugs to treat central nervous system disorders. The improvements will be made over the next two years, and will accommodate 60 new scientists, including bioinformaticists, bringing the total number of researchers working at the facility to about 150, according to the company.

Filed under

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.